Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia

We reviewed the outcome of 671 patients 65 years of age or older with newly diagnosed acute myeloid leukemia (AML) treated at our institution between 2000 and 2010 with intensive chemotherapy (n = 557) or azacitidine- or decitabine-based therapy (n = 114). Both groups were balanced according to cyto...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Quintás-Cardama, Alfonso, Ravandi, Farhad, Liu-Dumlao, Theresa, Brandt, Mark, Faderl, Stefan, Pierce, Sherry, Borthakur, Gautam, Garcia-Manero, Guillermo, Cortes, Jorge, Kantarjian, Hagop
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society of Hematology 2012
الموضوعات:
Clinical Trials and Observations
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3952725/
https://ncbi.nlm.nih.gov/pubmed/23071272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-06-436055
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة